REPORT ON GOFLA AND VODOCAT AT THE 4TH DEPARTMENT OF CARDIOLOGY - TAM DUC HEART HOSPITAL

On May 5, 2026, Medbolide Pharmaceutical JSC attended a scientific seminar hosted by Department of Cardiology 4 at Tam Duc Heart Hospital. The seminar was attended by doctors and nurses from the department and was chaired by Department Head Dr. Trần Thị Kim Thanh, a Board-Certified Specialist.

At the meeting, Dr. Nguyen Thai Binh, M.D., shared information about GOFLA (Apixaban 2.5 mg)—a factor Xa inhibitor and a new-generation anticoagulant used to treat, prevent recurrence, and halt the further development of blood clots—with the following key features:

• Reduces stroke and venous thromboembolism—superior to VKAs in patients with non-valvular atrial fibrillation
• Best efficacy in preventing VTE after hip and knee replacement surgery
• Recommended as the best anticoagulant for patients with end-stage chronic kidney disease by ACC/AHA/ACCP/HRS 2023; for patients aged 65 years or older by the American Geriatrics Society 2023

In addition, Dr. Nguyen Thai Binh also highlighted the superior benefits of Torsemide compared to Furosemide, based on scientific evidence from clinical studies. Torsemide is a loop diuretic with a superior mechanism of action compared to older diuretics, such as Furosemide, effectively reducing edema in patients with heart failure, kidney failure, and cirrhosis. Torsemide improves cardiac function and reduces the risk of death from heart failure. This is a product currently being used by doctors in the department under the brand name VODOCAT 5 (active ingredient: Torsemide 5 mg).

The presentation drew significant interest and praise from the doctors regarding the GOFLA and VODOCAT 5 products.

At the conclusion of the session, the company expressed its gratitude and hope to continue partnering with the hospital in providing effective solutions to enhance the quality of patient care. Medbolide Pharmaceutical Joint Stock Company is proud to be a trusted partner of Tam Duc Heart Hospital in supplying high-quality, effective medical products that contribute to the healthcare of the community.